Sector Chart Immutep Limited

Equities

Market Closed - Australian S.E. Other stock markets 02:10:06 2024-05-08 EDT			5-day change	1st Jan Change
0.46 ^AUD	-5.15%		+6.98%	+33.33%

05-02	Immutep Limited Reports Positive Initial Clinical Data Reported from Efti Combined with Radiotherapy and Checkpoint Inhibitor from Phase II Trial in Soft Tissue Sarcoma	CI
05-02	Immutep Validates Initial Efficacy of Immunotherapy Medication in Phase Two Cancer Trial	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes